title: Infliximab for IPILIMUMAB-Related Colitis-Letter.
authors.affiliation: Southampton NIHR Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton Tremona Road, Southampton, United Kingdom. University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, United Kingdom. e.arriola-aperribay@soton.ac.uk.
authors.forename: Edurne
authors.initials: E
authors.lastname: Arriola
authors.affiliation: University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, United Kingdom.
authors.forename: Matthew
authors.initials: M
authors.lastname: Wheater
authors.affiliation: Southampton NIHR Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton Tremona Road, Southampton, United Kingdom. University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, United Kingdom.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Karydis
authors.affiliation: Southampton NIHR Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton Tremona Road, Southampton, United Kingdom. University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, United Kingdom.
authors.forename: Gareth
authors.initials: G
authors.lastname: Thomas
authors.affiliation: Southampton NIHR Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton Tremona Road, Southampton, United Kingdom. University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, United Kingdom.
authors.forename: Christian
authors.initials: C
authors.lastname: Ottensmeier
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003092:Colitis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D000074324:Ipilimumab; D008545:Melanoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab; D000069285:Infliximab